Pallas Capital Advisors LLC Alnylam Pharmaceuticals, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 3,408 shares of ALNY stock, worth $933,757. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,408
Previous 3,321
2.62%
Holding current value
$933,757
Previous $913,000
12.27%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
648Shares Held
110MCall Options Held
1.28MPut Options Held
1.22M-
Capital World Investors Los Angeles, CA16.5MShares$4.52 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.46 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.62 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.44 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.36 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...